14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
IG vs ANIK: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Anika Therapeutics Inc (ANIK) is the stronger overall head-to-head candidate over Principal Investment Grade Corporate Active ETF (IG) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). IG carries a Unified Composite Score of 45.4/100 (HOLD) at $19.61 (N/M Forward P/E, N/A operating margin), whereas ANIK carries 48.5/100 (HOLD) at $12.92 (12.9x Forward P/E, -0.1% operating margin).
Technical & Structure Timing Caution: IG is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 39.4); meanwhile ANIK is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 22.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IG vs ANIK. Trailing 12-month operating profitability (IG N/A vs ANIK -0.1%) and valuation multiples (IG N/M vs ANIK 12.9x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Drug Manufacturers - Specialty & Generic value chain with $179.5M market capitalization and -0.1% operating margin.
OpEx & R&D Reinvestment63.5% of Rev ($78M)
90D Engineering Disclosures0 Published
Investor FAQ IG vs ANIK Key Questions & Quantitative Answers
As of Nov 16, 2026, Anika Therapeutics Inc (ANIK) is the stronger overall head-to-head candidate over Principal Investment Grade Corporate Active ETF (IG) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). IG carries a Unified Composite Score of 45.4/100 (HOLD) at $19.61 (N/M Forward P/E, N/A operating margin), whereas ANIK carries 48.5/100 (HOLD) at $12.92 (12.9x Forward P/E, -0.1% operating margin). Technical & Structure Timing Caution: IG is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 39.4); meanwhile ANIK is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 22.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
ANIK leads the Growth & Scale pillar: IG posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with ANIK at +10.0% YoY revenue growth and -50.5% YoY earnings growth on $123M TTM revenue (63.4% gross margin, -0.1% operating margin). On trailing 12-month operating scale, IG generates N/A in USD-normalized revenue versus $123M for ANIK. In operating R&D and SG&A reinvestment, IG deploys N/A (0 90-day corporate R&D disclosures) versus 63.5% of Rev ($78M) (0 disclosures) for ANIK.
ANIK screens cheaper on headline valuation multiples. IG trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas ANIK trades at 12.9x Forward P/E, 13.4x Trailing P/E, 1.34x PEG, and 1.3x EV/Revenue (1.9% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against IG (N/A ROE) versus ANIK (-0.2% ROE) capital efficiency.
In options market volatility and institutional positioning, IG carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.18β · 7% Vol realized risk). By comparison, ANIK carries 39.5% implied volatility (6th %ile, Compressed (<25th %ile)), a 1.43x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (0.91β · 98% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.